Market Chameleon (Mon, 20-Apr 5:39 AM ET)
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ
PRNewswire (Mon, 20-Apr 3:10 AM ET)
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Alamar Biosciences - Class A trades on the NASDAQ stock market under the symbol ALMR.
As of April 24, 2026, ALMR stock price climbed to $24.84 with 705,217 million shares trading.
ALMR has a market cap of $1.69 billion. This is considered a Small Cap stock.
The top ETF exchange traded funds that ALMR belongs to (by Net Assets): ARKG, LFSC.
ALMR support price is $22.72 and resistance is $25.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALMR shares will trade within this expected range on the day.
